Back

Risk factors and clinical effects of late leaflet thrombosis after transcatheter aortic valve replacement

28 August 2022 (08:15 - 08:45)
Organised by:
Congress Presentation Part of: Thrombosis and anticoagulation in valvular heart disease Intervention ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Minjung Bak

Samsung Medical Center, Seoul (Korea (Republic of))

4 More presentations in this session

Presentation thumbnail
To compare efficacy and safety of direct oral anticoagulants in patients with concurrent atrial fibrillation and bioprosthetic heart valve repair or replacement: a systematic review and meta-analysis
Doctor A. Kaur (New York City, US)
Abstract Slides
Presentation thumbnail
Oral anticoagulant treatment in patients with atrial fibrillation early after valvular intervention: a nationwide cohort study
Associate Professor C. Christersson (Uppsala, SE)
Abstract Slides
Presentation thumbnail
Comparing direct oral anticoagulants versus vitamin k antagonist in patients with atrial fibrillation after transcatheter aortic valve replacement: an updated meta-analysis
Doctor A. Kaur (New York City, US)
Abstract Slides
Presentation thumbnail
Hypoattenuated leaflet thickening is associated with silent brain injury
Doctor A. Nagy (Budapest, HU)
Abstract Slides

Access the full session

Session thumbnail
Thrombosis and anticoagulation in valvular heart disease

The Event

Event poster

ESC Congress 2022

28 August 2022 08:15 CET
You may be interested in
thumbnail
Congress Presentation
Clinical and anatomical predictors of early in-hospital stroke after transcatheter aortic valve implantation
21 March 2026
thumbnail
Congress Presentation
Treatment of left intraventricular thrombi-a real-life experience of a tertiary center
29 June 2021
thumbnail
Congress Presentation
Skirted prosthetic valves are associated with increased risk of subclinical leaflet thrombosis following transcatheter aortic valve replacement: a multicenter study
29 August 2025
thumbnail
Congress Presentation
Are traditional cardiovascular risk factors also related to aortic valve stenosis?
20 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources